Predict your next investment

HEALTHCARE | Drug Development
afnm.com

See what CB Insights has to offer

Founded Year

2000

Stage

Debt | Alive

Total Raised

$44.9M

Last Raised

$11.9M | 8 yrs ago

About Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company developing a class of antibiotics that target the bacterial fatty acid synthesis (FASII) pathway. AFN-1252, the company's lead clinical compound, is a highly-potent, small molecule antibiotic for both oral and IV treatment of staphylococcal infections, including MRSA and all other drug-resistant strains.

Affinium Pharmaceuticals Headquarter Location

200 Front Street West Suite 3004

Toronto, Ontario, M5V 3K2,

Canada

416-645-6613

Latest Affinium Pharmaceuticals News

Ontario investment in biotech pays off

Apr 8, 2015

April 07 Print This Article Share it With Friends The Ontario Capital Growth Corporation (OCGC) has announced that it has received more than three times its investment in Affinium Pharmaceuticals after the company’s acquisition by Debiopharm International. The acquisition to this Swiss-based global biopharmaceutical company has given OCGC $19 million. OCGC made its initial investment into Toronto-based Affinium in 2011, alongside other investors including Canadian Genesys Capital Management. “As Canada’s most active early stage life sciences venture investor, one of the biggest challenges we face is getting capital together to make investments like these,” said Damian Lamb, Managing Director at Genesys. “As the lead investor, Genesys worked with OCGC and our international partners to provide the financial resources necessary for Affinium’s success.” Senior Affinium management have joined with partners including Debiopharm to launch Nobelex Biotech Inc, which will focus on the development of anti-infection drugs. Based in the Toronto MaRS Discovery District, the company has already begun research and is quickly expanding its employee base.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Affinium Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Affinium Pharmaceuticals is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

14,139 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Affinium Pharmaceuticals Patents

Affinium Pharmaceuticals has filed 16 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/8/2013

1/9/2018

Metabolism, EC 2.3.1, Antibiotics, Protein domains, EC 1.1.1

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/8/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/9/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Metabolism, EC 2.3.1, Antibiotics, Protein domains, EC 1.1.1

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Affinium Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Affinium Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.